Characterization of Mesenchymal-Fibroblast Cells Using the Col1a2 Promoter/Enhancer.

Area of Science:

• Fibrosis research
• Extracellular matrix (ECM) regulation
• Gene regulation in mesenchymal cells

Background:

• Fibrotic diseases are characterized by excessive extracellular matrix (ECM) deposition, primarily collagen types I and III, produced by fibroblasts and other mesenchymal cells.
• Targeting fibroblast-specific gene regulation is crucial for controlling ECM deposition and limiting fibrotic scarring.
• Previous work identified an enhancer 17 kb upstream of the Col1a2 gene, active in mesenchymal cells during development and injury.

Purpose of the Study:

• To provide protocols for identifying novel fibroblast-specific enhancers.
• To detail the generation of transgenic constructs using identified enhancers for studying collagen transcription.
• To outline methods for utilizing these tools in transgenic mice for research on fibrotic diseases.

Main Methods:

• Characterization of an enhancer region upstream of the Col1a2 gene.
• Generation of transgenic mice using the enhancer to drive reporter genes (e.g., beta-galactosidase, luciferase).
• Application of cre/lox systems for conditional gain and loss of function studies in mice.

Main Results:

• The Col1a2 enhancer drives transgene expression in mesenchymal cells, correlating with collagen type I deposition.
• The enhancer serves as an informative reporter for collagen transcription.
• Protocols are provided for enhancer identification, construct generation, and transgenic animal production.

Conclusions:

• The characterized Col1a2 enhancer is a valuable tool for monitoring collagen transcription in mesenchymal cells.
• This approach facilitates the study of fibrotic processes and the development of antifibrotic therapies.
• The provided protocols enable researchers to generate and utilize similar reporter systems for diverse applications in regenerative medicine and disease modeling.